Tenax Therapeutics (TENX) Other Non-Current Assets (2011 - 2024)
Tenax Therapeutics (TENX) reported Other Non-Current Assets of $1117.0 for Q3 2024, little changed on a YoY basis from $1117.0 in Q4 2023, and little changed sequentially from $1117.0 in Q2 2024.
Tenax Therapeutics (TENX) Other Non-Current Assets (2011 - 2024) Analysis & Trends
Tenax Therapeutics (TENX) has 13 years of Other Non-Current Assets data on file, last reported at $1117.0 in Q3 2024.
- For the quarter ending Q3 2024, Other Non-Current Assets changed 0.0% year-over-year to $1117.0; the trailing twelve-month figure through Sep 2024 stood at $1117.0 (changed 0.0% YoY), and the FY2023 full-year result was $1000.0, down 89.53% from the prior year.
- Other Non-Current Assets held at $1117.0 in Q3 2024, from $1117.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $9552.0 in Q4 2022 to a low of $1000.0 in Q4 2023.
- A 5-year average of $5791.5 and a median of $8435.0 in 2020 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets advanced 13.24% in 2022 and slumped 89.53% in 2023, its largest moves.
- Tracing TENX's Other Non-Current Assets over 5 years: stood at $8435.0 in 2020, then changed by 0.0% to $8435.0 in 2021, then rose by 13.24% to $9552.0 in 2022, then tumbled by 89.53% to $1000.0 in 2023, then advanced by 11.7% to $1117.0 in 2024.
- Business Quant data shows TENX's Other Non-Current Assets at $1117.0 in Q3 2024, $1117.0 in Q2 2024, and $1117.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Tenax Therapeutics | 67,856.40 | 67,856.40 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 1,117.00 |
| Jun 30, 2024 | 1,117.00 |
| Mar 31, 2024 | 1,117.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | 1,117.00 |
| Jun 30, 2023 | 1,117.00 |
| Mar 31, 2023 | 1,117.00 |
| Dec 31, 2022 | 9,552.00 |
| Sep 30, 2022 | 8,435.00 |
| Jun 30, 2022 | 8,435.00 |
| Mar 31, 2022 | 8,435.00 |
| Dec 31, 2021 | 8,435.00 |
| Sep 30, 2021 | 8,435.00 |
| Jun 30, 2021 | 8,435.00 |
| Mar 31, 2021 | 8,435.00 |
| Dec 31, 2020 | 8,435.00 |
| Sep 30, 2020 | 8,435.00 |
| Jun 30, 2020 | 8,435.00 |
| Mar 31, 2020 | 8,435.00 |
| Dec 31, 2019 | 8,435.00 |